Rosty Raykov - Sep 5, 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Rosty Raykov
Stock symbol
FENC
Transactions as of
Sep 5, 2025
Transactions value $
$0
Form type
4
Date filed
9/8/2025, 06:05 PM
Previous filing
Sep 4, 2025
Next filing
Oct 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Raykov Rosty Director C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK /s/ Rosty Raykov 2025-09-08 0001468316

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Options Exercise $88.7K +36.2K +70.87% $2.45 87.3K Sep 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Options Options Exercise -$88.7K -36.2K -2.16% $2.45 1.64M Sep 5, 2025 options 36.2K $2.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.